AndresOSorianoMD

Oncology • Englewood, FL

Physician

Join to view full profile

Dr. Soriano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Soriano's full profile

Already have an account?

Office
Florida Cancer Specialists (ENG)
714 Doctors Drive
Englewood, FL 34223
Phone+1 941-460-1300

Fax+1 941-460-1306
Is this information wrong?

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2004 - 2007
Forest Park HospitalResidency, Internal Medicine, 2003 - 2004
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2001 - 2003
Universidad de Guayaquil, School of Medicine.Class of 1998

Certifications & Licensure

FL State Medical License 2013 - 2026
TX State Medical License 2005 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014

Clinical Trials

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer Start of enrollment: 2015 Jul 29
Completed
Phase 1

Publications & Presentations

PubMed

30 citations
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC.
Roy S. Herbst, Hendrik Tobias Arkenau, Johanna C. Bendell, Edward Arrowsmith, Martin Wermke, Andres O. Soriano, Nicolas Penel, Rafael Santana-Davila, Helge Bischoff, I...> ;Journal of Thoracic Oncology. 2021 Feb 1
17 citations
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.
Ian Chau, Nicolas Penel, Andres O. Soriano, Hendrik-Tobias Arkenau, Jennifer L. Cultrera, Rafael Santana-Davila, Emiliano Calvo, Christophe Le Tourneau, Lars Zender, J...> ;Cancers. 2020 Oct 15
168 citations
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a m...
Roy S. Herbst, Hendrik-Tobias Arkenau, Rafael Santana-Davila, Emiliano Calvo, Luis Paz-Ares, Philippe A. Cassier, Johanna C. Bendell, Nicolas Penel, Matthew G Krebs, J...> ;The Lancet. Oncology. 2019 Aug 1
123 citations
Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers.
Fadi Braiteh, Andres O. Soriano, Guillermo Garcia-Manero, David S. Hong, Marcella M. Johnson, Leandro de Padua Silva, H. Yang, Stefanie Alexander, Johannes E. A. Wolff...> ;Clinical Cancer Research. 2008 Oct 1
301 citations
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome
Andres O. Soriano, H. Yang, Stefan Faderl, Zeev Estrov, Francis J. Giles, Farhad Ravandi, Jorge E. Cortes, William G. Wierda, Souzanne Ouzounian, Andres Quezada, Sherr...> ;Blood. 2007 Oct 1
1 citations
Constrictive bronchiolitis after treatment of colon cancer with 5-fluorouracil.
Martin A. Valdivia-Arenas, Andres O. Soriano, Roque B. Arteaga> ;Chemotherapy. 2007 Aug 21
103 citations
Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature.
Andres O. Soriano, Michael A. Thompson, Joan H. Admirand, Luis Fayad, Alma Rodriguez, Jorge E. Romaguera, Fredrick B. Hagemeister, Barbara Pro> ;American Journal of Hematology. 2007 Aug 1
8 citations
Metamizole use among Hispanics in Miami: report of a survey conducted in a primary care setting.
Santiago Garcia, Mariana Canoniero, Gilberto Lopes, Andres O. Soriano> ;Southern Medical Journal. 2006 Sep 1
127 citations
Endothelial Microparticles and Platelet and Leukocyte Activation in Patients With the Metabolic Syndrome
Roque B. Arteaga, Julio A. Chirinos, Andres O. Soriano, Wenche Jy, Lawrence L. Horstman, Joaquin J. Jimenez, Armando J. Mendez, Alexandre C. Ferreira, Eduardo de March...> ;The American Journal of Cardiology. 2006 Jul 1
Phase I study of low-dose hypomethylating agent azacitidine (5-AC) combined with the histone deacetylase inhibitor valproic acid (VPA) in patients with advanced cancers.
Braiteh F, Soriano A, Luis CH, David HS, Ng C, Garcia-Manero G, Kurzrock R> ;J. Clin. Oncol.. 2006-06-20
138 citations
Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe se...
Andres O. Soriano, Wenche Jy, Julio A. Chirinos, Martin A. Valdivia, Hermes Velasquez, Joaquin J. Jimenez, Lawrence L. Horstman, Daniel H. Kett, Roland M. H. Schein, Y...> ;Critical Care Medicine. 2005 Nov 1
268 citations
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism.
Julio A. Chirinos, Gustavo A. Heresi, Hermes Velasquez, Wenche Jy, Joaquin J. Jimenez, Eugene Ahn, Lawrence L. Horstman, Andres O. Soriano, Juan P. Zambrano, Yeon S. Ahn> ;Journal of the American College of Cardiology. 2005 May 3
Join now to see all